ketanserin has been researched along with harmine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colau, D; Dolusić, E; Frédérick, R; Larrieu, P; Masereel, B; Moineaux, L; Pilotte, L; Pochet, L; Stroobant, V; Van den Eynde, B; Wouters, J | 1 |
Gorzalka, BB; Mendelson, SD | 1 |
Brierley, DI; Davidson, C | 1 |
3 other study(ies) available for ketanserin and harmine
Article | Year |
---|---|
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Immunologic Factors; Indoles; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Tryptophan Oxygenase | 2011 |
Harmine reverses the inhibition of lordosis by the 5-HT2 antagonists pirenperone and ketanserin in the female rat.
Topics: Alkaloids; Animals; Estradiol; Female; Harmine; Ketanserin; Ovariectomy; Piperidines; Posture; Progesterone; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sexual Behavior, Animal | 1986 |
Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell.
Topics: Animals; Brain; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Agonists; Harmine; Ketanserin; Male; Moclobemide; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin | 2013 |